AI Visibility Scorecard
Glycomine
glycomine.com · Healthcare
Borderline visible. AI bots can crawl Glycomine, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 8 times
Claude · Apple Intelligence · Meta AI · ShapBot
#12,663 of 924,420 in Healthcare for AI visibility
26
5
AEO Visibility
iBorderline · 4.7/10
10
Muse Index Score
iAI agent readiness
Basic · 10/100
0
AI Adoption
iNone detected · 0/100
About Glycomine
from our crawl and measurement
Glycomine describes itself simply: "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment." When AI engines look at it, they find little to work with. It scores 4.7 out of 10.
Our crawl found structured data on the page (WebPage, BreadcrumbList, WebSite), an llms.txt file for AI models and a sitemap.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Strong
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Strong
Recognized in AI knowledge graphs.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.7/10, Glycomine is crawlable but under-signaled - fixable, and the signals above are where to start.
Frequently Asked Questions
What is PMM2-CDG?
PMM2-CDG (also known as CDG-1A or CDG Type 1a) is a rare genetic disease of glycosylation. While currently approved therapies only treat symptoms and are not disease-modifying, Glycomine hopes to change that with the clinical development of GLM101 (ClinicalTrials.gov Identifier: NCT06892288), a mannose-1-phosphate replacement therapy. ABOUT PMM2-CDG
Is this your brand?
The exact fixes for Glycomine
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Glycomine.
Source & Attribution
Scored by Engagemii on August 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/glycomine
Cite this score: Engagemii (2026). "AEO Score for Glycomine." Retrieved from https://engagemii.com/aeo/brands/glycomine
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform